NYSE:RTO Rentokil Initial (RTO) Stock Price, News & Analysis → Fidelity, Bezos, Goldman Bet Big on Tiny Biotech (From Behind the Markets) (Ad) Free RTO Stock Alerts $26.43 -0.14 (-0.53%) (As of 05/8/2024 ET) Add Compare Share Share Today's Range$26.25▼$26.4850-Day Range$25.52▼$32.6352-Week Range$23.39▼$41.55Volume354,407 shsAverage Volume715,432 shsMarket Capitalization$13.34 billionP/E RatioN/ADividend Yield2.53%Price Target$38.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsDividendFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsDividendFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Get Rentokil Initial alerts: Email Address Rentokil Initial MarketRank™ Stock AnalysisAnalyst RatingHold2.00 Rating ScoreUpside/Downside43.8% Upside$38.00 Price TargetShort InterestBearish1.08% of Float Sold ShortDividend StrengthWeakBased on Four FactorsSustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings Growth14.86%From $1.48 to $1.70 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.29 out of 5 starsBusiness Services Sector250th out of 312 stocksDisinfecting & Pest Control Services Industry1st out of 1 stocks 3.0 Analyst's Opinion Consensus RatingRentokil Initial has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on 1 buy rating, 2 hold ratings, and 1 sell rating.Amount of Analyst CoverageRentokil Initial has only been the subject of 2 research reports in the past 90 days.Read more about Rentokil Initial's stock forecast and price target. Previous Next 2.0 Short Interest Percentage of Shares Shorted1.08% of the float of Rentokil Initial has been sold short.Short Interest Ratio / Days to CoverRentokil Initial has a short interest ratio ("days to cover") of 6.9.Change versus previous monthShort interest in Rentokil Initial has recently increased by 29.29%, indicating that investor sentiment is decreasing significantly. Previous Next 1.7 Dividend Strength Dividend YieldRentokil Initial pays a meaningful dividend of 2.57%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthRentokil Initial has only been increasing its dividend for 1 years.Dividend SustainabilityBased on earnings estimates, Rentokil Initial will have a dividend payout ratio of 39.41% next year. This indicates that Rentokil Initial will be able to sustain or increase its dividend.Read more about Rentokil Initial's dividend. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for RTO. Previous Next 0.6 News and Social Media Coverage MarketBeat Follows5 people have added Rentokil Initial to their MarketBeat watchlist in the last 30 days. This is an increase of 67% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Rentokil Initial insiders have not sold or bought any company stock.Percentage Held by InstitutionsOnly 9.91% of the stock of Rentokil Initial is held by institutions.Read more about Rentokil Initial's insider trading history. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for Rentokil Initial are expected to grow by 14.86% in the coming year, from $1.48 to $1.70 per share.Price to Earnings Growth RatioRentokil Initial has a PEG Ratio of 2.27. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioRentokil Initial has a P/B Ratio of 2.63. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Smallcaps DailyThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySee how with its ongoing expansion and development of its diverse and promising product pipeline, this small-cap NYSE company is positioned to be a dominant and innovative leader in the nanomedicine and antiviral therapy space.Click to read About Rentokil Initial Stock (NYSE:RTO)Rentokil Initial plc, together with its subsidiaries, provides route-based services in North America, the United Kingdom, rest of Europe, Asia, the Pacific, and internationally. It offers a range of pest control services for rodents, and flying and crawling insects, as well as other forms of wildlife management for commercial customers. The company provides hygiene services, including the provision and maintenance of products, such as soap and hand sanitizer dispensers, hand dryers, air care and purification, cubicle and surface sanitizers, feminine hygiene units, toilet paper dispensers, and floor protection mats. In addition, it engages in the supply and maintenance of workwear and protective equipment. Further, the company offers property care services; and provides a range of specialist cleaning services, such as graffiti removal deep cleaning of kitchens and washrooms, trauma cleaning, and flood or fire damage cleaning, as well as specialist medical and hygiene services. Rentokil Initial plc was founded in 1903 and is headquartered in Crawley, the United Kingdom.Read More RTO Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart RTO Stock News HeadlinesApril 29, 2024 | msn.comThe United States of Termites: How the Tiny, Traveling Pests Are Taking Over—And Where They’re Going NextApril 26, 2024 | tmcnet.comVTG Enhances Digital Transformation and Cloud Capabilities with Acquisition of Vana SolutionsMay 8, 2024 | Smallcaps Daily (Ad)The #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySee how with its ongoing expansion and development of its diverse and promising product pipeline, this small-cap NYSE company is positioned to be a dominant and innovative leader in the nanomedicine and antiviral therapy space.April 24, 2024 | prnewswire.comServe Robotics Enters Production Agreement with Magna to Scale Robot ManufacturingApril 22, 2024 | prnewswire.comServe Robotics Inc. Announces Closing of $40 Million Public Offering and Uplisting to the Nasdaq Capital Market Under New Ticker "SERV"April 19, 2024 | prnewswire.comHOW TO KEEP PESTS FROM BUZZING THROUGH COMMUNITY CLEAN-UP EVENTS THIS EARTH DAYApril 18, 2024 | msn.comRentokil shares slip as investors mull mixed picture on crucial US businessApril 18, 2024 | seekingalpha.comRentokil Initial plc (RTO) Q1 2024 Sales/Trading Statement Call TranscriptMay 8, 2024 | Smallcaps Daily (Ad)The #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySee how with its ongoing expansion and development of its diverse and promising product pipeline, this small-cap NYSE company is positioned to be a dominant and innovative leader in the nanomedicine and antiviral therapy space.April 18, 2024 | seekingalpha.comQ1 2024 Sales/ Trading Statement CallApril 17, 2024 | investing.comCiti maintains Buy rating on Rentokil stockApril 17, 2024 | prnewswire.comServe Robotics Inc. Announces Pricing of $40 Million Public Offering and Uplisting to the Nasdaq Capital Market Under New Ticker "SERV"April 17, 2024 | finance.yahoo.comGEO or RTO: Which Is the Better Value Stock Right Now?April 17, 2024 | markets.businessinsider.comLongeveron Announces Exercise of Warrants for $6.2 Million Gross ProceedsApril 16, 2024 | markets.businessinsider.comPaxMedica Receives Emergency Request for IV Suramin from African Health Ministry for Use in Treating Fatal Sleeping SicknessApril 15, 2024 | msn.comTemenos shares rally as independent review says short seller’s claims were ‘misleading’April 10, 2024 | markets.businessinsider.comRadixweb Named Among the Best Outsourcing Service Providers by the IAOP’s Global Outsourcing 100April 4, 2024 | msn.comVF and GMG to open 300 stores in MENA and SEA regionsApril 3, 2024 | businessinsider.comJain Global hires distressed debt trader Jeff BershApril 3, 2024 | markets.businessinsider.comTruist Financial Reaffirms Their Hold Rating on Veeva Systems (VEEV)March 28, 2024 | usnews.com5 Best Termite Companies in Orange County, CaliforniaMarch 21, 2024 | prnewswire.comTERMINIX® IS NAMED THE OFFICIAL PEST CONTROL PARTNER OF THE UNITED SOCCER LEAGUEMarch 19, 2024 | seekingalpha.comVertex: EPS Better Than Expected, Cloud Offerings, And CheapMarch 18, 2024 | msn.comGerman company pledges 400 manufacturing jobs in Wilson, boosting Eastern NC pharmaMarch 15, 2024 | finance.yahoo.comRentokil Initial plc: Rentokil Earmarks Extra Sales and Marketing Spending to Remedy Weak Organic Growth in North AmericaMarch 15, 2024 | msn.comRentokil Initial plc declares $0.3784 dividendMarch 13, 2024 | msn.comGlobal ecosystem contributes trillions in its services with key synergies and tradeoffs, study findsSee More Headlines Receive RTO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Rentokil Initial and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/06/2020Ex-Dividend for 5/28 Dividend4/04/2024Today5/08/2024Dividend Payable5/28/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorBusiness Services Industry Disinfecting & pest control services Sub-IndustryN/A Current SymbolNYSE:RTO CUSIPN/A CIK930157 Webwww.rentokil-initial.com Phone441293858000FaxN/AEmployees58,600Year FoundedN/APrice Target and Rating Average Stock Price Target$38.00 High Stock Price Target$47.00 Low Stock Price Target$29.00 Potential Upside/Downside+43.8%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage4 Analysts Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E Ratio17.86 P/E Growth2.27Net IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$4.59 billion Price / Sales2.90 Cash Flow$2.00 per share Price / Cash Flow13.22 Book Value$10.06 per share Price / Book2.63Miscellaneous Outstanding Shares504,910,000Free FloatN/AMarket Cap$13.34 billion OptionableNot Optionable Beta1.07 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report Key ExecutivesMr. Andrew M. Ransom (Age 61)CEO & Executive Director Comp: $3.41MMr. Stuart M. Ingall-Tombs (Age 57)CFO & Executive Director Comp: $1.97MMr. Bradley S. Paulsen (Age 48)CEO of North America & Member of Management Board Mr. Mark Purcell (Age 58)Chief Information Officer Ms. Katharine RycroftHead of Investor RelationsMr. Malcolm PadleyDirector of Corporate CommunicationsMr. Gary Booker (Age 53)Chief Marketing, Innovation & Strategy Officer Ms. Vanessa Evans (Age 55)Group Human Resources Director Mr. John Myers (Age 66)CEO of US Pest Control Mr. Phill Wood (Age 58)Managing Director of UK & Sub-Saharan Africa More ExecutivesKey CompetitorsRB GlobalNYSE:RBAGrabNASDAQ:GRABMorningstarNASDAQ:MORNGen DigitalNASDAQ:GENGFL EnvironmentalNYSE:GFLView All CompetitorsInstitutional OwnershipMotley Fool Wealth Management LLCBought 25,313 shares on 5/8/2024Ownership: 0.092%Sei Investments Co.Bought 11,202 shares on 5/7/2024Ownership: 0.013%Oppenheimer & Co. Inc.Bought 14,667 shares on 5/7/2024Ownership: 0.007%Susquehanna International Group Ltd.Bought 29,370 shares on 5/7/2024Ownership: 0.006%Oppenheimer Asset Management Inc.Bought 2,482 shares on 5/7/2024Ownership: 0.006%View All Institutional Transactions RTO Stock Analysis - Frequently Asked Questions Should I buy or sell Rentokil Initial stock right now? 4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Rentokil Initial in the last year. There are currently 1 sell rating, 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" RTO shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in RTO, but not buy additional shares or sell existing shares. View RTO analyst ratings or view top-rated stocks. What is Rentokil Initial's stock price target for 2024? 4 Wall Street analysts have issued 12-month target prices for Rentokil Initial's shares. Their RTO share price targets range from $29.00 to $47.00. On average, they anticipate the company's stock price to reach $38.00 in the next year. This suggests a possible upside of 43.8% from the stock's current price. View analysts price targets for RTO or view top-rated stocks among Wall Street analysts. How have RTO shares performed in 2024? Rentokil Initial's stock was trading at $28.61 on January 1st, 2024. Since then, RTO shares have decreased by 7.6% and is now trading at $26.43. View the best growth stocks for 2024 here. Are investors shorting Rentokil Initial? Rentokil Initial saw a increase in short interest during the month of April. As of April 15th, there was short interest totaling 5,430,000 shares, an increase of 29.3% from the March 31st total of 4,200,000 shares. Based on an average trading volume of 783,200 shares, the days-to-cover ratio is currently 6.9 days. Approximately 1.1% of the company's stock are sold short. View Rentokil Initial's Short Interest. How were Rentokil Initial's earnings last quarter? Rentokil Initial plc (NYSE:RTO) posted its quarterly earnings results on Thursday, August, 6th. The company reported $0.40 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.36 by $0.04. The business earned $534 million during the quarter, compared to the consensus estimate of $516.72 million. The company's revenue for the quarter was down 4.6% compared to the same quarter last year. During the same period in the previous year, the business earned $0.50 earnings per share. How often does Rentokil Initial pay dividends? What is the dividend yield for Rentokil Initial? Rentokil Initial declared a semi-annual dividend on Thursday, March 14th. Investors of record on Friday, April 5th will be given a dividend of $0.3784 per share on Tuesday, May 28th. This represents a yield of 1.6%. The ex-dividend date is Thursday, April 4th. This is an increase from the stock's previous semi-annual dividend of $0.18. Read our dividend analysis for RTO. Is Rentokil Initial a good dividend stock? Rentokil Initial (NYSE:RTO) pays an annual dividend of $0.67 per share and currently has a dividend yield of 2.57%. Read our dividend analysis for RTO. What ETF holds Rentokil Initial's stock? Motley Fool Global Opportunities ETF holds 294,520 shares of RTO stock, representing 1.80% of its portfolio. When does Rentokil Initial's quiet period expire? Rentokil Initial's quiet period expires on Tuesday, May 28th. Rentokil Initial had issued 10,000,000 shares in its initial public offering on April 18th. The total size of the offering was $40,000,000 based on an initial share price of $4.00. During Rentokil Initial's quiet period, insiders and any underwriters that worked on the IPO are restricted from issuing any research reports or earnings estimates for the company because of regulations issued by the Securities and Exchange Commission. Following the end of the company's quiet period, it's expected that the brokerages that served as underwriters on the stock will initiate research coverage on the company. Who are Rentokil Initial's major shareholders? Rentokil Initial's stock is owned by a number of institutional and retail investors. Top institutional investors include Nichols & Pratt Advisers LLP MA (0.12%), Motley Fool Wealth Management LLC (0.09%), Iridian Asset Management LLC CT (0.07%), Raymond James & Associates (0.07%), Bar Harbor Wealth Management (0.06%) and Sumitomo Mitsui Trust Holdings Inc. (0.02%). View institutional ownership trends. How do I buy shares of Rentokil Initial? Shares of RTO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSE:RTO) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyElon Musk Secret Crypto Plot ExposedCrypto 101 MediaAI “wealth window” is closing June 25thParadigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingGold Set to EXPLODE!Gold Safe ExchangeCharles Payne Demystifies OptionsUnstoppable ProsperityThe AI Stock that’s Disrupting Every IndustryStockEarnings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rentokil Initial plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
